Longitudinal evaluation of external quality assessment results for CA 15-3, CA 19-9, and CA 125 [PDF]
Frontiers in Molecular BiosciencesBackgroundTumor markers are established laboratory tools that help to diagnose, estimate prognosis, and monitor the course of cancer. For meaningful decision-making in patient care, it is essential that methods and analytical platforms demonstrate high ...
Marcel Kremser +8 more
doaj +6 more sources
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance [PDF]
Breast, 2020 Background: Serum tumour markers, cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) are not routinely recommended for detecting breast cancer recurrence and monitoring treatment. In this study, we aim to evaluate the diagnostic accuracy of
J.X. Hing +6 more
doaj +3 more sources
CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia [PDF]
Scientific Reports, 2022 The severity of lung involvement is the main prognostic factor in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Carbohydrate antigen 15-3 (CA 15-3), a marker of lung damage and fibrosis, could help predict the prognosis of SARS ...
José Antonio Ros-Lucas +16 more
doaj +5 more sources
Tumor marker CA 15-3 in breast cancer patients [PDF]
Acta Medica Academica, 2015 Objective. The aim of this study was to determine whether there is a correlation between the serum concentration of the tumor marker CA 15-3 and breast cancer, which has not been proven by the existence of regional and distant metastases, and breast ...
Hanifa Fejzić +3 more
doaj +5 more sources
Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural Effusions [PDF]
Asian Pac J Cancer Prev, 2017 Introduction: Pleural effusion diagnosis plays an important role in determining treatment strategies. The aim of this study was to determine the diagnostic capacity of tumor markers CA 15-3 and NSE solely or in combination in differentiating the nature ...
Saba MA +4 more
europepmc +5 more sources
Novel sensor for the determination of CA 15-3 in serum of breast cancer patients based on Fe-gallic acid complex doped in modified cellulose polymer thin films. [PDF]
RSC Adv, 2023 Fe–gallic acid MOF embedded in an epoxy methyl cellulose polymer (CMC) thin film was synthesized and characterized by different micro-analytical tools such as: FE-SEM/EDX, XPS analysis, XRD analysis, FT-IR, and fluorescence spectroscopy.
AlGhamdi HA +6 more
europepmc +2 more sources
Diagnostic impact of CEA and CA 15-3 on chemotherapy monitoring of breast cancer patients. [PDF]
J Circ Biomark, 2022 Introduction: Serum tumor markers have emerged as an effective tool to determine prognosis and treatment efficiency in different cancer types. This study aimed to explore the chemotherapy monitoring efficiency and prognostic sensitivity of tumor ...
Hasan D.
europepmc +2 more sources
An electrochemically synthesized molecularly imprinted polymer for highly selective detection of breast cancer biomarker CA 15-3: a promising point-of-care biosensor. [PDF]
RSC AdvIn this study, a molecularly imprinted polymer film (MIP) was prepared on the surface of a disposable carbon screen-printed electrode (C-SPE) using (3-acrylamidopropyl)trimethylammonium chloride (AMPTMA) as a functional monomer and the cancer biomarker ...
Oliveira D +2 more
europepmc +2 more sources
Cancer Treatment and Research Communications, 2021 Background: We aimed to evaluate the association of serum carcinoembryonic antigen (CEA) and cancer antigen 15–3 (CA 15–3) levels with clinicopathological parameters in patients with breast cancer (BC) and their efficiency for the prediction of ...
Meliha Melin Uygur, Mahmut Gümüş
doaj +2 more sources
Association of tumor markers CA 15-3, CEA, and CA 125 with [18F]NaF PET findings in breast cancer patients [PDF]
Frontiers in OncologyIntroductionBreast cancer often metastasizes to bone, and [18F]NaF PET is commonly used to detect skeletal involvement. This study examines the association of serum CA 15-3, CEA, and CA 125 with [18F]NaF PET findings in breast cancer to guide clinical ...
Arvin Naeimi +9 more
doaj +2 more sources